Literature DB >> 12484775

Retinol-binding protein-deficient mice: biochemical basis for impaired vision.

Silke Vogel1, Roseann Piantedosi, Sheila M O'Byrne, Yuko Kako, Loredana Quadro, Max E Gottesman, Ira J Goldberg, William S Blaner.   

Abstract

We reported previously that mice lacking plasma retinol-binding protein (RBP) are phenotypically normal except that they display impaired vision at the time of weaning. This visual defect is associated with greatly diminished eyecup levels of retinaldehyde and is reversible if the mutants are maintained for several months on a vitamin A-sufficient diet. Here we provide a biochemical basis for the visual phenotype of RBP-deficient mice. This phenotype does not result from inadequate milk total retinol levels since these are not different for RBP-deficient and wild-type mice. The eye, unlike all other tissues that have been examined, takes up dietary retinol very poorly. Moreover, compared to other tissues, the eye displays a strong preference for retinol uptake when retinol is delivered bound to RBP. The poor uptake of dietary retinol by the eye coupled with its marked ability to take up retinol from RBP, we propose, provides a basis for the impaired vision observed in weanling RBP-deficient mice. Further study of the mutants suggests that the impaired vision is reversible because the eyes of mutant mice slowly acquire sufficient retinol from the low levels of retinol present in their circulation either bound to albumin or present in lipoprotein fractions. Thus, the eye is unlike other tissues in the body in that it shows a very marked preference for acquiring retinol needed to support vision from the retinol-RBP complex and is unable to meet adequately its retinol need through uptake of recently absorbed dietary retinol. This provides an explanation for the impaired vision phenotype of RBP-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484775     DOI: 10.1021/bi0268551

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

2.  Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina.

Authors:  Marcin Golczak; Akiko Maeda; Grzegorz Bereta; Tadao Maeda; Philip D Kiser; Silke Hunzelmann; Johannes von Lintig; William S Blaner; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

3.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  Genetically modified mouse models to study hepatic neutral lipid mobilization.

Authors:  Guenter Haemmerle; Achim Lass
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-05       Impact factor: 5.187

Review 5.  Maternal-fetal transfer and metabolism of vitamin A and its precursor β-carotene in the developing tissues.

Authors:  Elizabeth Spiegler; Youn-Kyung Kim; Lesley Wassef; Varsha Shete; Loredana Quadro
Journal:  Biochim Biophys Acta       Date:  2011-05-19

Review 6.  The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates.

Authors:  Made Airanthi K Widjaja-Adhi; Marcin Golczak
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-11-23       Impact factor: 4.698

Review 7.  The membrane receptor for plasma retinol-binding protein, a new type of cell-surface receptor.

Authors:  Hui Sun; Riki Kawaguchi
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

Review 8.  Delivery of retinoid-based therapies to target tissues.

Authors:  Alexander R Moise; Noa Noy; Krzysztof Palczewski; William S Blaner
Journal:  Biochemistry       Date:  2007-03-23       Impact factor: 3.162

Review 9.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

10.  Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.

Authors:  Fabienne Soulet; Witold W Kilarski; Philipp Antczak; John Herbert; Roy Bicknell; Francesco Falciani; Andreas Bikfalvi
Journal:  BMC Genomics       Date:  2010-09-14       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.